Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2025
Comprehensive Genomic Analysis Reveals Molecular Heterogeneity in Pediatric ALK-Positive Anaplastic Large Cell Lymphoma, Timothy I Shaw, Stanley Pounds, Xueyuan Cao, et al.
Retrospective Analysis of Cement Extravasation Rates in Vertebroplasty, Kyphoplasty, and Bone Tumor Radiofrequency Ablation, Soun Sheen, Prit Hasan, Xiaowen Sun, et al.
The Influence of the Microbiome on Radiotherapy and DNA Damage Responses, Aadil Sheikh and Michael A Curran
Research Hotspots and Trends in the Field of Immune Checkpoint Inhibitors (ICIs) for Cervical Cancer: A Bibliometric Study From 2014 to 2024, Chaoyan Shen, Juan Zhang, Guanyu Zhang, et al.
Survival-Inferred Fragility of Statistical Significance in Phase III Oncology Trials, Alexander D Sherry, Yufei Liu, Pavlos Msaouel, et al.
Reproducibility of Statistically Significant Phase III Oncology Trials: An In Silico Meta-Epidemiological Analysis, Alexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Treatment Group-Specific Inferences in Phase III Randomized Oncology Trials, Alexander D Sherry, Adina H Passy, Joseph Abi Jaoude, et al.
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial, Alexander D Sherry, Bilal A Siddiqui, Cara Haymaker, et al.
Cardiovascular Risk Factors and Genetic Risk in Transthyretin V142I Carriers, Naman S Shetty, Mokshad Gaonkar, Akhil Pampana, et al.
Immunotherapy Targeting a Leader Sequence Cathepsin G-derived Peptide, Chunhua Shi, Ze Tian, Jun Yan, et al.
Nuclear poly(A)-Binding Protein and Nucleolin Utilize Their RNA Recognition Motifs to Read Par Chains, Leilei Shi, Morgan Dasovich, John R Horton, et al.
Virus Against Cancer: Paradigm-Shifting Biological Concepts, Dong Ho Shin, Marta M Alonso, Candelaria Gomez-Manzano, et al.
DNA Methylation Markers of Insulin Resistance Surrogate Measures in the Atherosclerosis Risk in Communities (ARIC) Study, Jeewoen Shin, Jan Bressler, Megan L Grove, et al.
From Epithelium to Therapy: Transitional Cells in Lung Fibrosis, Sarah Y Shin, Jichao Chen, Irit Milman Krentsis, et al.
Characterizing Circulating Rare Cells in Peripheral Blood for Detecting and Monitoring Multiple Myeloma and Precursor States, Stephanie N Shishido, Jeremy Mason, Mohamed Kamal, et al.
Epac1 Deletion Attenuates Müller Glial Pathological Activation and Mitigates Retinal Neurodegeneration in Ischemia-Induced Retinopathy, Shuizhen Shi, Fan Xia, Zhongqiao Lu, et al.
Complement Activity and Autophagy Are Dysregulated in the Lungs of Patients With Nonresolvable COVID-19 Requiring Lung Transplantation, Pooja Shivshankar, Stacey L Mueller-Ortiz, Aleksey Y Domozhirov, et al.
Correction: Complement Activity and Autophagy Are Dysregulated in the Lungs of Patients With Nonresolvable COVID-19 Requiring Lung Transplantation, Pooja Shivshankar, Stacey L Mueller-Ortiz, Aleksey Y Domozhirov, et al.
Bayesian-Weighted Mendelian Randomization Reveals Sleep Apnea Syndrome Mediates the BMI-Chronic Pain Link, Wenbao Shi, Jing Luo, Liu Yang, et al.
Guanine Nucleotide Biosynthesis Blockade Impairs Mll Complex Formation and Sensitizes Leukemias to Menin Inhibition, Xiangguo Shi, Minhua Li, Zian Liu, et al.
CAT: A Conditional Association Test for Microbiome Data Using a Permutation Approach, Yushu Shi, Liangliang Zhang, Kim-Anh Do, et al.
Challenges and Opportunities in Multidisciplinary Supportive Care During Radiotherapy for Head and Neck Cancer, Jeffrey C Shogan, Anna Lee, and Yvonne M Mowery
Clinical Use of Measurable Residual Disease in Adult All: Recommendations From a Panel of Us Experts, Nicholas J Short, Ibrahim Aldoss, Daniel J DeAngelo, et al.
Molecular Characterization and Predictors of Relapse in Patients With Ph + All After Frontline Ponatinib and Blinatumomab, Nicholas J Short, Hagop Kantarjian, Ken Furudate, et al.
Long-Term Outcomes in FLT3-Mutated Acute Myeloid Leukemia After Frontline Hypomethylating Agent, Venetoclax and a FLT3 Inhibitor, Nicholas J Short, Sanam Loghavi, Musa Yilmaz, et al.